Antibiotic resistance occurs when bacteria survive exposure to an antibiotic, then multiply and pass their survival traits to other bacteria. It’s driven by a simple evolutionary principle: when an antibiotic kills most bacteria in a population but a few survive due to genetic advantages, those survivors reproduce and eventually dominate. In the United States alone, more than 2.8 million antibiotic-resistant infections happen each year, causing over 35,000 deaths.
The process isn’t new. Researchers discovered a bacterial enzyme capable of breaking down penicillin in 1940, a year before the drug was even used to treat its first patient. Resistance has been a biological inevitability from the start, but human behavior has dramatically accelerated it.
Selection Pressure: The Core Process
Every time antibiotics enter a bacterial population, they create what scientists call selection pressure. The drug kills susceptible bacteria and clears space for any bacteria that happen to carry resistance traits. With the competition wiped out, resistant bacteria multiply freely. This isn’t a matter of bacteria “learning” to resist the drug. It’s a numbers game: in any large bacterial population, a few individuals already carry genetic variations that let them survive. The antibiotic shifts the competitive balance in their favor.
Sub-lethal doses of antibiotics make this problem worse. When bacteria are exposed to concentrations too low to kill them, resistant strains still gain a survival edge without the susceptible strains being fully eliminated. This creates a slow, steady enrichment of resistance in the population. It’s one reason why not finishing a prescribed course of antibiotics, or using antibiotics at low doses in agriculture, contributes so heavily to the problem.
How Bacteria Acquire Resistance Genes
Bacteria can develop resistance through their own random genetic mutations, but they have a far more efficient trick: sharing resistance genes with each other, even across different species. This horizontal gene transfer happens three main ways.
In conjugation, one bacterium builds a tiny bridge (called a pilus) to a neighboring cell and passes a copy of its DNA through it. This is the most direct form of gene sharing and can spread resistance between completely unrelated bacterial species.
In transformation, bacteria pick up free-floating DNA from their environment. When a bacterial cell dies and bursts open, its genetic material spills out. Other bacteria can absorb that DNA and incorporate resistance genes into their own genome.
In transduction, viruses that infect bacteria accidentally package bacterial genes alongside their own DNA. When the virus moves on to infect another bacterium, it delivers those hitchhiking genes to a new host. This means a bacterium can acquire resistance without ever having been exposed to an antibiotic.
These sharing mechanisms are why resistance spreads so alarmingly fast. A single resistant bacterium doesn’t just pass its advantage to its offspring. It can hand resistance directly to bacteria that have never encountered the drug.
Five Ways Bacteria Defeat Antibiotics
Once a bacterium has the right genes, it deploys specific defense strategies against the drug. The CDC identifies five main resistance mechanisms.
- Blocking entry. Bacteria can change or reduce the doorways in their outer membrane, preventing the antibiotic from getting inside the cell in the first place.
- Pumping the drug out. Bacteria use molecular pumps embedded in their cell walls to actively eject antibiotics before the drugs can do damage. Some of these pumps can expel multiple types of antibiotics at once.
- Destroying the drug. Bacteria produce enzymes that break down or chemically alter the antibiotic, rendering it useless. This is exactly what researchers observed in 1940 with penicillin.
- Changing the target. Antibiotics work by binding to specific structures inside bacteria. If a bacterium alters the shape of that target, the drug can no longer attach and do its job.
- Bypassing the target entirely. Some bacteria develop alternative biological pathways that avoid the structure the antibiotic attacks, making the drug irrelevant even if it enters the cell.
A single bacterium can use more than one of these strategies simultaneously, and different resistance mechanisms can stack up over time, creating bacteria that shrug off multiple drug classes.
Agricultural Antibiotic Use
An estimated 50% to 80% of all antibiotics produced worldwide go to agriculture, not human medicine. Livestock receive antibiotics to treat infections but also, in many countries, to promote growth and prevent disease in crowded conditions. Because dosing in agriculture is far less controlled than in clinical settings, animals and the surrounding environment are frequently exposed to sub-lethal antibiotic concentrations, exactly the conditions that breed resistance.
Resistant bacteria from agricultural settings reach humans through multiple routes: contaminated food, water runoff from farms, and direct contact with animals. The exact contribution of agricultural antibiotic use to resistance in human infections is difficult to quantify, but researchers consider it far from negligible. Resistant bacteria don’t respect the boundary between farm and clinic.
Which Bacteria Are the Biggest Threat
The World Health Organization maintains a priority pathogen list to guide global research efforts. The 2024 update classifies several bacteria as critical threats. These include resistant strains of Klebsiella pneumoniae, Acinetobacter, and E. coli (all gram-negative bacteria with naturally tough outer membranes that make them harder to treat), along with drug-resistant tuberculosis.
High-priority pathogens requiring urgent attention include resistant Salmonella, Shigella, the bacterium responsible for gonorrhea, and Staphylococcus aureus (the organism behind MRSA infections). These bacteria cause common infections that are becoming progressively harder to treat with existing drugs.
Why Resistance Accelerates
Several human behaviors compound the biological process. Overprescription of antibiotics for viral infections (which antibiotics cannot treat) exposes bacteria to drugs unnecessarily. Patients who stop taking antibiotics early because they feel better may leave behind the most resilient bacteria. Poor sanitation and infection control in hospitals allow resistant strains to spread between patients. International travel moves resistant bacteria across borders within hours.
Each of these factors circles back to the same mechanism: giving bacteria repeated exposure to antibiotics without fully eliminating them. The surviving population grows more resistant with each round. When those resistant bacteria share their genes with other species, the problem compounds exponentially. In the U.S., when infections from C. difficile (a bacterium closely associated with antibiotic overuse) are included alongside resistant infections, the annual toll exceeds 3 million infections and 48,000 deaths.
Antibiotic resistance is not a distant or theoretical risk. It is an active, accelerating process shaped by biology that humans cannot change and behaviors that humans can.